Search Results 1331-1340 of 16161 for Epilepsy (Partial Onset)

1. Study of Validated Biomarkers in Urine for Patients with Adenocarcinoma of the Prostate - Mayo Clinic

   Patient has prior focal ablation (e.g. HIFU or cryoablation) of prostate cancer. Patient has had a urinary tract infection within 14 days of collection ...

2. Focus Areas - Alzheimer's Disease Research Center - Mayo Clinic Research

   The Alzheimer's Disease Research Center studies the entire spectrum of aging, from normal aging to mild cognitive impairment to dementia in cooperation with the ...

3. Publications - Eduardo E. Benarroch, M.D. - Mayo Clinic

   Nuclei-specific thalamic connectivity predicts seizure frequency in drug-resistant medial temporal lobe epilepsy. Neuroimage Clin. 2019; 21:101671 Epub 2019 ...

4. Headache Clinical Trials - Mayo Clinic Research

   The purpose of this study is to predict migraine headache onset from changes in speech in people who have a history of migraines. ... epilepsy patients admitted ...

5. Clinical Neurophysiology, Electroencephalography Fellowship (Florida) - Department and Faculty

   ... well as epilepsy. The Department of Neurology is capable of evaluating and treating patients with complex neurological disorders requiring clinical ...

6. Clinical Research Study With Clazosentan to Evaluate Its Effects on Preventing Complications Due to the Narrowing of the Blood Vessels (Vasospasm) in the Brain, Caused by Bleeding Onto the Surface of the Brain (REACT) - Mayo Clinic

   If breastfeeding, agreement must be obtained to refrain for the duration of the treatment with study drug and until 30 days post-study drug discontinuation.

7. A Study to Evaluate Cardiopulmonary Complications in Systemic Sclerosis - Mayo Clinic

   About this study. The purpose of this study is to assess whether our not the percentage of pulmonary related vascular structures (PRVS) determined by the ...

8. Patient Care and Health Information - Mayo Clinic

   Patient online services. See your results and records as fast as your clinician does. Get updated appointment schedules and instructions.

9. A Clinical Use Application for the Humanitarian Use Device Exemption Use Protocol of TheraSphere for Treatment of Unresectable Primary or Secondary Liver Neoplasia - Mayo Clinic

   This protocol allows multiple treatments with TheraSphere® that may be delivered on an outpatient basis. Patients may receive a single dose to a liver lobe or ...

10. Chronic myelogenous leukemia - Symptoms and causes - Mayo Clinic

    Learn about chronic myelogenous leukemia symptoms and causes. Find out how CML is treated, including targeted therapy and bone marrow transplant.